Transferrin receptor antibodies
US7572895B2 · kind B2 · utility
16Cited by
23References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2005 |
| Grant date | Aug 11, 2009 |
| Priority date | — |
| Expiry date | Mar 22, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides further characterization of the disease and cancer-associated antigen, transferrin receptor. The invention also provides a novel family of antibodies that bind to the transferrin receptor, methods of diagnosing and treating various human cancers and diseases that express transferrin receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.